Chloroquine Treatment for Uncomplicated Malaria
Introduction to Chloroquine Dosing
- For uncomplicated malaria caused by chloroquine-sensitive species, the World Health Organization recommends administering chloroquine phosphate 1000 mg salt (600 mg base) initially, followed by 500 mg salt (300 mg base) at 6, 24, and 48 hours, for a total dose of 2500 mg salt (1500 mg base) or 25 mg/kg over 3 days 1, 2
Species-Specific Dosing
- The Centers for Disease Control and Prevention recommends that for P. vivax, P. ovale, P. malariae, and P. knowlesi, the total cumulative dose should be 2500 mg salt (1500 mg base) or 25 mg/kg 1, 2, 3
- For pediatric patients with uncomplicated malaria, the American Academy of Pediatrics recommends an initial dose of 10 mg base/kg at hour 0 (maximum 600 mg base) 4
Critical Considerations
- The Infectious Diseases Society of America notes that chloroquine phosphate tablets contain 500 mg salt = 300 mg base, while chloroquine sulfate tablets contain 200 mg salt = 150 mg base, requiring 6 tablets initially, then 3 tablets at 6, 24, and 48 hours 1, 2
- The World Health Organization warns that chloroquine-resistant P. vivax occurs in Papua New Guinea and Indonesia, and recommends using artemisinin-based combinations instead 1, 2
Special Populations
- The American College of Obstetricians and Gynecologists recommends using standard adult chloroquine dosing in pregnant women, as chloroquine is safe in all trimesters 1, 4, 5
- The National Kidney Foundation states that no dose adjustment is needed for patients with renal failure, as chloroquine is primarily hepatically metabolized 5
Radical Cure for P. vivax and P. ovale
- The Centers for Disease Control and Prevention recommends adding primaquine 30 mg base daily for 14 days (adults) or 0.3 mg/kg/day for 14 days (children) to eradicate hypnozoites, but notes that G6PD status should be checked before primaquine due to hemolysis risk 1, 2, 3
Monitoring and Follow-up
- The World Health Organization recommends directly observing all doses when possible to ensure adherence, and repeating thick blood smear if symptoms persist beyond 3 days 3, 4